The automated analyzers market size has grown strongly in recent years. It will grow from $5.39 billion in 2025 to $5.79 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to manual and semi-automated testing methods, limited laboratory workforce efficiency, increasing clinical testing volumes, growth of diagnostic laboratories, reliance on conventional analyzers.
The automated analyzers market size is expected to see strong growth in the next few years. It will grow to $7.6 billion in 2030 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to advancement in fully automated analyzers, integration with ai and big data analytics, rising demand for rapid diagnostics, expansion of genomics and proteomics research, adoption of point-of-care testing solutions. Major trends in the forecast period include increasing adoption of automated laboratory systems, rising demand for high-throughput sample processing, integration of multi-functional analyzers in labs, growth in clinical diagnostics and research applications, enhanced accuracy and standardization in analytical testing.
The rising prevalence of chronic diseases is anticipated to drive the growth of the automated analyzers market in the coming years. The prevalence of chronic diseases is increasing due to aging populations, unhealthy lifestyle patterns, and growing urbanization worldwide. Automated analyzers are utilized in chronic disease management to provide efficient and accurate diagnostic testing, supporting early detection, continuous monitoring, and treatment of conditions such as diabetes, cardiovascular diseases, and kidney disorders. For instance, in June 2023, according to a report published by Kidney Research UK, a UK-based non-profit organization, approximately 7.2 million individuals in the UK were living with chronic kidney disease, accounting for more than 10% of the population. Of these, 3.25 million people were in advanced stages of the disease, while an additional 3.9 million were in the early stages. By 2033, the number of people affected by chronic kidney disease is projected to increase to 7.61 million. Therefore, the growing prevalence of chronic diseases is contributing to the growth of the automated analyzers market.
Leading companies operating in the automated analyzers market are focusing on developing innovative solutions such as automated clinical chemistry analyzers to improve efficiency, accuracy, and testing throughput in diagnostic laboratories. Automated clinical chemistry analyzers are advanced laboratory instruments designed to perform a wide range of chemical tests on blood and other bodily fluids with minimal human intervention, thereby improving operational efficiency and diagnostic accuracy. For example, in January 2024, Beckman Coulter, a US-based manufacturing company, launched the DxC 500 AU Chemistry Analyzer, representing a significant advancement in automated clinical chemistry testing. Featuring more than 120 high-quality assays, the analyzer is designed to enhance the capabilities of satellite and independent community hospital laboratories. It integrates advanced automation, streamlined workflows, and standardized reagents to increase testing efficiency and support clinical decision-making while complementing central hub laboratories within hub-and-spoke healthcare systems.
In April 2024, Valmet, a Finland-based technology company, acquired the process gas chromatography business from Siemens Healthineers AG for $113.05 million. This acquisition supports Valmet’s strategy to strengthen its automation segment and enhance its process automation capabilities, particularly in gas chromatography and process analyzer systems. The acquired business will be integrated into Valmet’s automation systems division under a newly established unit focused on analyzer products and integration, further reinforcing its position in this area. Siemens Healthineers AG is a Germany-based engineering and manufacturing company specializing in automated analyzers.
Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc, bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc.
North America was the largest region in the automated analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the automated analyzers market by increasing the cost of imported components such as sensors, microfluidic chips, and precision electronics. Segments including hematology and immuno-based analyzers are particularly impacted, with regions like Asia-Pacific and Europe facing higher import duties. This has raised production costs and affected pricing for end users such as hospitals and diagnostic labs. Positively, tariffs are encouraging local manufacturing, investment in domestic supply chains, and innovation in cost-efficient analyzer solutions.
The automated analyzers market research report is one of a series of new reports that provides automated analyzers market statistics, including automated analyzers industry global market size, regional shares, competitors with a automated analyzers market share, detailed automated analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the automated analyzers industry. This automated analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Automated analyzers are laboratory machines that perform repetitive analytical tests with minimal human involvement. They increase productivity by processing large numbers of samples quickly and accurately and are widely used in clinical, chemical, and hematology testing.
The main types of automated analyzers include biochemistry analyzers, immuno-based analyzers, hematology analyzers, and others. Biochemistry analyzers are laboratory systems used to determine the concentration of various biochemical components in biological samples for diagnostic and research applications. They process sample types such as blood, urine, serum, plasma, and others. These analyzers are utilized in applications including drug discovery, genomics, proteomics, bioanalysis, clinical diagnostics, and more, and are used by end users such as hospitals and clinics, diagnostic laboratories, pharmaceutical companies, biotechnology firms, and others.
The automated analyzers market consists of sales of biochemistry analyzers, hematology analyzers, immunoassay analyzers, blood gas analyzers, and molecular analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The automated analyzers market size is expected to see strong growth in the next few years. It will grow to $7.6 billion in 2030 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to advancement in fully automated analyzers, integration with ai and big data analytics, rising demand for rapid diagnostics, expansion of genomics and proteomics research, adoption of point-of-care testing solutions. Major trends in the forecast period include increasing adoption of automated laboratory systems, rising demand for high-throughput sample processing, integration of multi-functional analyzers in labs, growth in clinical diagnostics and research applications, enhanced accuracy and standardization in analytical testing.
The rising prevalence of chronic diseases is anticipated to drive the growth of the automated analyzers market in the coming years. The prevalence of chronic diseases is increasing due to aging populations, unhealthy lifestyle patterns, and growing urbanization worldwide. Automated analyzers are utilized in chronic disease management to provide efficient and accurate diagnostic testing, supporting early detection, continuous monitoring, and treatment of conditions such as diabetes, cardiovascular diseases, and kidney disorders. For instance, in June 2023, according to a report published by Kidney Research UK, a UK-based non-profit organization, approximately 7.2 million individuals in the UK were living with chronic kidney disease, accounting for more than 10% of the population. Of these, 3.25 million people were in advanced stages of the disease, while an additional 3.9 million were in the early stages. By 2033, the number of people affected by chronic kidney disease is projected to increase to 7.61 million. Therefore, the growing prevalence of chronic diseases is contributing to the growth of the automated analyzers market.
Leading companies operating in the automated analyzers market are focusing on developing innovative solutions such as automated clinical chemistry analyzers to improve efficiency, accuracy, and testing throughput in diagnostic laboratories. Automated clinical chemistry analyzers are advanced laboratory instruments designed to perform a wide range of chemical tests on blood and other bodily fluids with minimal human intervention, thereby improving operational efficiency and diagnostic accuracy. For example, in January 2024, Beckman Coulter, a US-based manufacturing company, launched the DxC 500 AU Chemistry Analyzer, representing a significant advancement in automated clinical chemistry testing. Featuring more than 120 high-quality assays, the analyzer is designed to enhance the capabilities of satellite and independent community hospital laboratories. It integrates advanced automation, streamlined workflows, and standardized reagents to increase testing efficiency and support clinical decision-making while complementing central hub laboratories within hub-and-spoke healthcare systems.
In April 2024, Valmet, a Finland-based technology company, acquired the process gas chromatography business from Siemens Healthineers AG for $113.05 million. This acquisition supports Valmet’s strategy to strengthen its automation segment and enhance its process automation capabilities, particularly in gas chromatography and process analyzer systems. The acquired business will be integrated into Valmet’s automation systems division under a newly established unit focused on analyzer products and integration, further reinforcing its position in this area. Siemens Healthineers AG is a Germany-based engineering and manufacturing company specializing in automated analyzers.
Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc, bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc.
North America was the largest region in the automated analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the automated analyzers market by increasing the cost of imported components such as sensors, microfluidic chips, and precision electronics. Segments including hematology and immuno-based analyzers are particularly impacted, with regions like Asia-Pacific and Europe facing higher import duties. This has raised production costs and affected pricing for end users such as hospitals and diagnostic labs. Positively, tariffs are encouraging local manufacturing, investment in domestic supply chains, and innovation in cost-efficient analyzer solutions.
The automated analyzers market research report is one of a series of new reports that provides automated analyzers market statistics, including automated analyzers industry global market size, regional shares, competitors with a automated analyzers market share, detailed automated analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the automated analyzers industry. This automated analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Automated analyzers are laboratory machines that perform repetitive analytical tests with minimal human involvement. They increase productivity by processing large numbers of samples quickly and accurately and are widely used in clinical, chemical, and hematology testing.
The main types of automated analyzers include biochemistry analyzers, immuno-based analyzers, hematology analyzers, and others. Biochemistry analyzers are laboratory systems used to determine the concentration of various biochemical components in biological samples for diagnostic and research applications. They process sample types such as blood, urine, serum, plasma, and others. These analyzers are utilized in applications including drug discovery, genomics, proteomics, bioanalysis, clinical diagnostics, and more, and are used by end users such as hospitals and clinics, diagnostic laboratories, pharmaceutical companies, biotechnology firms, and others.
The automated analyzers market consists of sales of biochemistry analyzers, hematology analyzers, immunoassay analyzers, blood gas analyzers, and molecular analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Automated Analyzers Market Characteristics
3. Automated Analyzers Market Supply Chain Analysis
4. Global Automated Analyzers Market Trends and Strategies
5. Automated Analyzers Market Analysis of End Use Industries
7. Global Automated Analyzers Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Automated Analyzers Total Addressable Market (TAM) Analysis for the Market
9. Automated Analyzers Market Segmentation
10. Automated Analyzers Market Regional and Country Analysis
11. Asia-Pacific Automated Analyzers Market
12. China Automated Analyzers Market
13. India Automated Analyzers Market
14. Japan Automated Analyzers Market
15. Australia Automated Analyzers Market
16. Indonesia Automated Analyzers Market
17. South Korea Automated Analyzers Market
18. Taiwan Automated Analyzers Market
19. South East Asia Automated Analyzers Market
20. Western Europe Automated Analyzers Market
21. UK Automated Analyzers Market
22. Germany Automated Analyzers Market
23. France Automated Analyzers Market
24. Italy Automated Analyzers Market
25. Spain Automated Analyzers Market
26. Eastern Europe Automated Analyzers Market
27. Russia Automated Analyzers Market
28. North America Automated Analyzers Market
29. USA Automated Analyzers Market
30. Canada Automated Analyzers Market
31. South America Automated Analyzers Market
32. Brazil Automated Analyzers Market
33. Middle East Automated Analyzers Market
34. Africa Automated Analyzers Market
36. Automated Analyzers Market Competitive Landscape and Company Profiles
37. Automated Analyzers Market Other Major and Innovative Companies
40. Automated Analyzers Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Automated Analyzers Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses automated analyzers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for automated analyzers? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automated analyzers market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Biochemistry Analyzers; Immuno-Based Analyzers; Hematology Analyzers; Other Types2) By Sample Type: Blood; Urine; Serum; Plasma; Other Sample Types
3) By Application: Drug Discovery; Genomics; Proteomics; Bio Analysis; Clinical Diagnostics; Other Applications
4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Pharmaceutical And Biotechnology Companies; Other End Users
Subsegments:
1) By Biochemistry Analyzers: Clinical Biochemistry Analyzers; Point-of-Care Biochemistry Analyzers; Integrated Biochemistry Systems2) By Immuno-Based Analyzers: Immunoassay Analyzers; Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers; Chemiluminescent Immunoassay (CLIA) Analyzers
3) By Hematology Analyzers: Automated Hematology Analyzers; Flow Cytometry-Based Hematology Analyzers; Complete Blood Count (CBC) Analyzers
4) By Other Types: Molecular Analyzers; Urinalysis Analyzers; Coagulation Analyzers
Companies Mentioned: Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Honeywell International; Danaher Corporation; Siemens Healthineers AG; Becton Dickinson and Company; Tosoh Corporation; Agilent Technologies Inc.; Grifols S.A.; Xylem Inc.; Hitachi High-Tech Corporation; Mindray; PerkinElmer Inc; bioMérieux SA; Sysmex Corporation; Bruker Corporation; Horiba Medical; Randox Laboratories Ltd.; Nova Biomedical Corporation; Trinity Biotech Plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Automated Analyzers market report include:- Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Honeywell International
- Danaher Corporation
- Siemens Healthineers AG
- Becton Dickinson and Company
- Tosoh Corporation
- Agilent Technologies Inc.
- Grifols S.A.
- Xylem Inc.
- Hitachi High-Tech Corporation
- Mindray
- PerkinElmer Inc
- bioMérieux SA
- Sysmex Corporation
- Bruker Corporation
- Horiba Medical
- Randox Laboratories Ltd.
- Nova Biomedical Corporation
- Trinity Biotech Plc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.79 Billion |
| Forecasted Market Value ( USD | $ 7.6 Billion |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
